Tumor cell interactions with adhesion proteins and growth factors likely contribute to the metastatic cascade. Evidence is provided that insulin or insulin-like growth factor-mediated signals cooperate with the commonly expressed integrin ␣ v ␤ 5 to promote spontaneous pulmonary metastasis of multiple tumor cell types in both the chick embryo and severe combined immune deficiency mouse/human chimeric models. Expression of ␣ v ␤ 5 in tumor cells promoted their adhesion to vitronectin in vitro. However, cell motility required cytokine stimulation, which caused redistribution of ␣ -actinin to membrane-adhesive sites containing ␣ v ␤ 5. Significantly, ligation of ␣ v ␤ 5 and cytokine receptors were both required for spontaneous pulmonary metastasis of multiple tumor types even though it was not necessary for primary tumor growth. Thus, tumor cell metastasis can be regulated by a functional cooperation between cytokine signaling events and the adhesion receptor ␣ v ␤ 5 in a manner independent of tumor cell growth. These findings provide evidence that integrin ligation, in conjunction with cytokine activation, plays an important role in the dissemination of malignant tumor cells. ( J. Clin. Invest. 1997. 99:1390-1398.) 
Introduction
The spread of malignant tumor cells to secondary sites continues to be a major obstacle for the treatment of neoplastic disease. Recent reports implicate both cytokines and adhesion receptors in tumor cell invasion and metastasis (1) (2) (3) (4) (5) . In fact, a correlation has been established between specific integrins and metastatic behavior in vivo (6) (7) (8) .
Adhesion receptors of the integrin family promote cell attachment to proteins within the extracellular matrix and potentiate cellular migration and invasion (9) (10) (11) . Integrin ligation typically leads to organization of the actin cytoskeleton by direct or indirect association of integrin cytoplasmic domains with several cytoplasmic proteins including ␣ -actinin, talin, and focal adhesion kinase (12) (13) (14) (15) . However, little is known about how these molecular events regulate tumor cell motility and invasion. While integrin-mediated adhesion may be necessary for tumor cell motility and invasion, it is not sufficient. For example, human tumor cells typically express the integrin ␣ v ␤ 5, facilitating attachment to vitronectin. However, cells expressing ␣ v ␤ 5 require a tyrosine kinase receptor-mediated signaling event for motility on vitronectin (16) . Interestingly, tumor cells expressing ␣ v ␤ 3 migrate in vitro and metastasize in vivo without the need for exogenous cytokine stimulation (17) .
Recent studies demonstrate that cytokines such as insulin or insulin-like growth factor-1 potentiate tumor cell migration in vitro (18, 19) . In fact, tumor cells can secrete these cytokines, which may lead to autocrine stimulation of tumor cell growth and/or motility (20) (21) (22) (23) . Thus, it appears that cytokine receptors and adhesion molecules may cooperate functionally to promote cell motility in vitro and perhaps invasion and metastasis in vivo. In this report, evidence is provided that spontaneous tumor cell metastasis can be induced in a manner dependent on both cytokine stimulation and ligation of integrin ␣ v ␤ 5. These findings provide the first direct evidence that an integrin can functionally cooperate with a cytokine receptor to promote spontaneous tumor cell invasion and dissemination in vivo.
Methods
Antibodies, chemicals, and reagents. Monoclonal antibodies LM609 anti-␣ v ␤ 3, LM142 anti-human ␣ V, P1F6 anti-␣ v ␤ 5, and 661 antivitronectin have been described previously (24) . mAb W6/32 anti-MHC-I was obtained from American Type Culture Collection (Rockville, MD). mAb 7E2, specific for hamster ␤ 1 integrin, was graciously provided by Dr. Rudolph Juliano (University of North Carolina, Chapel Hill, NC). mAb ␣ IR3, anti-IGF-1 receptor was obtained from Oncogene Science Inc., (Cambridge, MA). Phycoeurythrinlabeled goat anti-mouse IgG was obtained from Southern Biotechnology Associates Inc. (Birmingham, AL). Insulin was obtained from Boehringer Mannheim GmbH (Mannheim, Germany). Insulin-like growth factor-1 was obtained from Genzyme Corp. (Cambridge, MA). Laminin was obtained from Upstate Biotechnology Inc. (Lake Placid, NY). Vitronectin was purified as previously described (25) . Bacterial collagenase was obtained from Worthington Biochemical Corp. (Freehold, NJ).
Cell lines and tissue culture. Hamster melanoma cell line CS-1 was obtained from Dr. Caroline Damsky (University of California at San Francisco, San Francisco, CA). CS-1 cells were selected for the lack of functional expression of both ␣ v ␤ 3 and ␣ v ␤ 5. ␤ 5CS-1 cell line was generated by transfection of full length cDNA encoding the ␤ 5 integrin subunit and has been described previously (26) . FG human pancreatic carcinoma cells and MCF-7PB human breast carcinoma cells, both of which express integrin ␣ v ␤ 5 but not ␣ v ␤ 3, have been described previously (16, 27) . All cell lines were cultured in RPMI-1640, Gibco Laboratories (Grand Island, NY), supplemented with 5% fetal bovine serum, 2 mM l -glutamine, and 50 g/ml gentamicin (Sigma Chemical Co., St. Louis, MO). Fresh human neonatal foreskins were obtained from the Cooperative Human Tissue Network (Cleveland, OH) and stored in sterile RPMI-1640 media supplemented with 2% FBS and 1% gentamycin.
Cell migration assays. Cell migration assays were performed using Transwell migration chambers as previously described (16) with minor modifications. Briefly, the under surface of the membranes (8-m pores) were coated with either vitronectin or laminin at a concentration of 10 g/ml. The lower chamber was filled with 0.5 ml of Fibroblast Basal Medium (FBM) containing 0.5% bovine serum albumin. CS-1 melanoma cells were serum starved for 16 h, and then treated with insulin (0.1-20 g/ml) for 30 min. CS-1 melanoma cells (10 5 ) in 0.1 ml of FBM-BSA were added to the upper wells of the Transwell chambers and allowed to migrate for 16 h. Similar experiments were performed in the presence of IGF-1 (20 ng/ml). For antibody inhibition experiments, cells were allowed to migrate in the presence of either mAbs P1F6 (anti-␣ v ␤ 5), 661 (antivitronectin), or LM609 (anti-␣ v ␤ 3) (25 g/ml). Cells migrating to the under side of the membrane were stained with 1% crystal violet. Migration was quantified by counting the number of stained cells per 40 ϫ field with an inverted microscope (BX-60; Olympus Corp., Lake Success, NY).
Immunofluorescence analysis of ␤ 5CS-1 cells stimulated with cytokine. CS-1 melanoma cells expressing integrin ␣ v ␤ 5 ( ␤ 5CS-1) were stimulated with either insulin (10 g/ml) or IGF-1 (20 ng/ml) for 30 min, and then allowed to attach to vitronectin-coated glass cover slips for 30 min at 37 Њ C. Growth factors were again added to the attached cells for an additional 15 min. Attached cells were extracted to remove non-cytoskeletal-associated cell material as previously described (28) . Fixed cells were stained with both anti-␣ v ␤ 5 antibody P1F6 (20 g/ml) and rabbit polyclonal anti-␣ -actinin (1:100) dilution for 1 h at 37 Њ C. Two-color staining was detected by incubation with both sheep anti-mouse FITC and goat anti-rabbit rhodamine-labeled secondary antibodies. Cell fluorescence was analyzed with a laser confocal microscope (Carl Zeiss Inc., Thornwood, NY) focused at the cell substratum interface (200 nm Z sections).
Chick embryo metastasis assay. The chick embryo metastasis assay was performed as described previously with some modifications (17, 29) . CS-1, ␤ 5CS-1, or FG human pancreatic carcinoma cells were stimulated 24 h before with 10 g/ml of insulin, 20 ng/ml IGF-1, or unstimulated. Tumor cells (5-10 ϫ 10 6 ) were inoculated on the chorioallantoic membrane (CAM) 1 of 9-or 10-d-old chick embryos in a total volume of 40 l RPMI. The embryos were allowed to incubate for a total of 7 to 9 d, at which time the embryos were killed. Tumors that formed at the primary site were excised, trimmed free of surrounding CAM tissue, and weights were determined. Pulmonary metastasis was assessed by determining the percentage of either hamster melanoma or human carcinoma cells present in a single cell suspension of whole lung tissue by flow cytometry. Single cell suspensions were prepared by resecting the chick lungs, mincing the tissue, and resuspending the tissue in 0.25% bacterial collagenase in PBS for 2 h at 37 Њ C with occasional vortexing. Cell suspensions were washed 4 ϫ with 2.5% BSA in PBS and fixed in 1.0% paraformaldyde for 15 min. Cell suspensions were washed as before and incubated in 2.5% BSA, 0.02% sodium azide in PBS for 24 h at 4 Њ C to block nonspecific binding sites. Flow cytometry was performed as previously described (17) using mAb 7E2, specific for hamster ␤ 1 integrin or mAb LM142 directed to human ␣ V integrin. For antibody inhibition experiments, embryos were injected intravenously with purified mAbs P1F6 or W6/32 (300 g/100 l), 24 h after initiation of tumor growth as previously described (29) .
Severe combined immune deficiency mouse/human chimeric model. Transplantation of human skin was performed as described previously (30) . Briefly, severe combined immune deficiency (SCID) mice were anesthetized and fresh full thickness human neonatal foreskin was sutured into place. The skin grafts were allowed to heal for 4 wk. CS-1, ␤ 5CS-1, or MCF-7PB human breast carcinoma cells were preincubated for 24 h with either insulin (10 g/ml) or IGF-1 (20 ng/ml), and then injected intradermally (2-4 ϫ 10 6 per animal) into the human skin. The tumors were allowed to grow for a total of 4 wk (melanoma tumors) or 10 wk (carcinoma tumors), at which time they were resected and wet weights and/or caliper measurements were determined. Lungs from tumor-bearing mice were dissected, washed 3 ϫ in sterile PBS, and incubated in Bouin's fixative for 8 h. Pulmonary metastasis was quantified by counting the number of surface lung nodules in a double blind fashion. Lungs were further analyzed by histological analysis. Briefly, 4-m sections of paraffin-embedded lungs were stained with hematoxylin and eosin as previously described (31 such as IGF-1, which can potentiate cell motility in vitro. In fact, we recently observed that cells expressing integrin ␣ v ␤ 5 could attach to vitronectin, but failed to migrate without exogenous growth factor stimulation (16) . Recent reports also suggest that cytokine stimulation of human breast carcinoma cells can promote vitronectin-dependent migration in vitro (32) . To investigate the biological relevance of cytokine-dependent ␣ v ␤ 5-directed motility on spontaneous metastasis in vivo, we examined the invasive and metastatic ability of both human pancreatic carcinoma (FG) and human breast carcinoma cells (MCF-7PB) in vivo. FG and MCF-7PB carcinoma cells were treated with or without insulin (10 g/ml) for 24 h. FG human pancreatic carcinoma cells were implanted onto the CAMs of 9-d-old chick embryos. 24 h after tumor cell implantation, embryos were injected intravenousely with either mAb P1F6 (anti-␣ v ␤ 5) or W6/32 (anti-MHC-I). The tumors were allowed to grow for a total of 9 d. FG human pancreatic carcinoma cells formed well defined solid tumors in the chick embryo with similar mean tumor weights irrespective of cytokine stimulation or antibody treatment ( Fig. 1 A ) . In contrast, Figure 4 . Effect of cytokine on localization of integrin ␣v␤5 and ␣-actinin. Unstimulated or insulin-(10 g/ml) stimulated ␤5CS-1 melanoma cells attached to vitronectin-coated glass cover slips were fixed, permeabilized, and costained with both anti-␣v␤5 antibody P1F6 and rabbit polyclonal anti-␣-actinin. Two-color staining was detected by incubation with both sheep anti-mouse FITC and goat anti-rabbit rhodamine-labeled secondary antibodies. (A) Unstimulated ␤5CS-1 cells. (B) Insulin (10 g/ml) stimulated ␤5CS-1 cells. Photographs were taken with a Zeiss laser confocal microscope focused at the cell substratum interface (594ϫ). Green, integrin ␣v␤5; red, ␣-actinin at the cell substrate interface (200 nm Z section); and yellow, colocalization between integrin ␣v␤5 and ␣-actinin. Identical results were obtained after IGF-1 stimulation (20 ng/ml).
Results

Cytokine stimulation of CS-1 cell migration. Tumor cell metastasis depends on the migration and invasive properties of individual tumor cells. This process may be enhanced by cytokines
insulin stimulation of FG cells caused a fourfold increase in pulmonary metastasis that was not only dependent on cytokine stimulation, but also appeared to require integrin ␣v␤5, since an antibody directed to ␣v␤5 (P1F6) significantly reduced this activity ( Fig. 1 B) . Interestingly, similar findings were obtained with human breast carcinoma MCF-7PB cells in the human/mouse chimeric model of metastasis. While insulin apeared to have little effect on the size of human breast carcinoma tumors grown within full thickness human skin, this treatment caused a three-to fourfold increase in pulmonary metastasis (Fig. 1, C and D) .
To further define the cooperative interaction between integrin ␣v␤5 and ligation of insulin or IGF-I receptors during invasive cell behavior, we examined the invasive and metastatic ability of CS-1 melanoma tumors in vivo since these CS-1 melanoma cells lacked ␤3 and ␤5 integrin subunits and thus fail to attach or migrate on vitronectin (17) . These melanoma cells were transfected with a cDNA encoding the ␤5 integrin subunit, enabling them to attach to vitronectin (26) . These ␣v␤5expressing CS-1 cells (␤5CS-1) were then tested for their ability to migrate towards the extracellular matrix proteins vitronectin or laminin in the presence or absence of insulin or IGF-1. As shown in Fig. 2 A, CS-1 cell migration toward vitronectin required both ␣v␤5 expression and exposure of cells to insulin or IGF-1 (data not shown). In contrast, CS-1 cell migration toward laminin was independent of either expression of ␣v␤5 or cytokine stimulation. Furthermore, cytokine stimulation did not alter the surface expression of integrin ␣v␤5 or induce the expression of ␣v␤3 as determined by flow cytometric analysis (data not shown). In fact, CS-1 cell migration on vitronectin was blocked with monoclonal antibodies directed to ␣v␤5 or vitronectin but not to ␣v␤3 (Fig. 2 B) . These find- ings demonstrate that insulin or IGF-1 can specifically stimulate an ␣v␤5-dependent motility response.
Ligation of IGF-1 receptor potentiates ␣v␤5-dependent CS-1 cell migration. Experiments were designed to determine whether ligation of the IGF-1 receptor is required for ␣v␤5dependent cell motility. CS-1 cell migration was analyzed in the presence or absence of a monoclonal antibody directed to the IGF-1 receptor. As shown in Fig. 3 A, IGF-1 induced ␤5CS-1 cell migration, which was specifically blocked by the addition anti-IGF-1 receptor antibody ␣IR3, whereas an isotype-matched control antibody had no effect. Furthermore, this effect was specific to migration as ␣IR3 had no effect on CS-1 cell adhesion to vitronectin (Fig. 3 B) . These results sup-port the contention that ␣v␤5-dependent CS-1 cell migration requires cooperation between the insulin-like growth factor receptor and integrin ␣v␤5.
Cytokine stimulation promotes the redistribution and colocalization of integrin ␣v␤5 and ␣-actinin. The cytoskeletal protein ␣-actinin, which associates with both actin and the cytoplasmic tail of integrin beta subunits, was recently implicated in cell motility since it preferentially localized to the leading edge of migrating cells (33) . Therefore, to investigate the biological response of CS-1 cells to cytokine stimulation, ␣v␤5expressing CS-1 cells attached to vitronectin were permeabilized and stained for the presence of the cytoskeletal protein ␣-actinin and integrin ␣v␤5. Unstimulated ␤5CS-1 cells at- tached to vitronectin and showed a distinct compartmentalization of ␣v␤5 and ␣-actinin ( Fig. 4 A) . However, after exposure of ␤5CS-1 cells to either IGF-1 or insulin, these cells showed a specific redistribution and extensive colocalization (yellow) of ␣v␤5 and ␣-actinin at the cell substrate interface as detected by confocal image analysis (Fig. 4 B) . Thus, cytokine stimulation of ␤5CS-1 cells that was sufficient to induce cell motility is associated with the colocalization of integrin ␣v␤5 and ␣-actinin in these melanoma cells. This association may provide a critical link between ␣v␤5 and the actin cytoskeleton necessary for migration of these cells on vitronectin.
Cytokine stimulation of CS-1 cell metastasis. To assess the biological significance of ␣v␤5-dependent CS-1 cell motility, we examined the growth and spontaneous metastatic properties of these CS-1 cells in the chick embryo and human skin/ mouse chimeric models. Control or ␤5CS-1 cells pretreated with or without cytokine were placed on the chorioallantoic membrane of 10-d-old chick embryos and allowed to propagate for 7 d. Primary tumors were then resected and weighed, and the lungs were removed to identify CS-1 cells that had established pulmonary metastases as described previously (17) . As shown in Fig. 5 A, the primary tumors that had developed were not significantly influenced by either the expression of ␣v␤5 (P Ͼ 0.580) and/or prior exposure of cells to either insulin or IGF-1 (P Ͼ 0.748). However, when ␤5CS-1 cells were exposed ex vivo to cytokine, the cells acquired the ability to spontaneously metastasize to the lungs of chick embryos (Fig.  5 B) . Importantly, neither ␣v␤5 expression alone or cytokine stimulation of ␣v␤5-negative CS-1 cells (CS-1) promoted tumor cell metastasis. To establish whether ␣v␤5 directly contributed to the metastatic properties of these cells, tumor-bearing animals were injected intravenously with monoclonal antibody directed to integrin ␣v␤5. This antibody specifically blocked spontaneous pulmonary metastasis of ␤5CS-1 cells (P Ͻ 0.002), yet had negligible effects on primary tumor growth (P Ͼ 0.210) (Fig. 5, C and D) . Together, these findings provide evidence for a functional cooperation between ligation of a cytokine receptor and integrin ␣v␤5 during spontaneous pulmonary metastasis in vivo.
CS-1 cell metastasis in the SCID mouse/human chimeric model. Primary melanomas develop in the skin and, once they invade vertically into the dermis, become highly metastatic. Therefore, we directly injected these ␤5CS-1 melanoma cells into the dermis of human skin transplanted on the flanks of SCID mice. ␤5CS-1 cells treated with or without insulin or IGF-1 were injected intradermally within the human skin as previously described (27) . The tumors were allowed to grow for 4 wk, at which time the mice were killed and the resulting primary tumors were resected and weighed. The lungs were removed to determine the extent of pulmonary metastasis. As shown in Fig. 6 A, cytokine-treated ␤5CS-1 cells formed numerous large, well defined metastatic lung lesions that could also be readily detected by histological analysis (Fig. 6 B) . In contrast, lungs from mice injected with unstimulated ␤5CS-1 cells (Fig. 6, C and D) or ␣v␤5-negative CS-1 cells (data not shown) treated with either insulin or IGF-1 showed few if any metastatic lung lesions. This metastatic behavior was not due to an increase in tumorgenicity since exposure to cytokine did not significantly influence the tumor size ( Fig. 7 A) ; however, it did cause a fivefold increase in metastatic lung lesions ( Fig.  7 B) . These results confirm our previous findings in the chick embryo and provide a second physiologically relevant example of a functional cooperation between ligation of a cytokine receptor and integrin ␣v␤5 during spontaneous tumor cell metastasis in vivo.
Discussion
Cell adhesion molecules and cytokines have been suggested to contribute to the metastatic spread of tumor cells (1-5, 34, 35) . Numerous studies have suggested possible mechanisms by which these distinct families of molecules could independently contribute to the metastatic cascade (3, 6, 22, 36, 37) . However, the possibility that cell adhesion molecules and cytokines func- tion cooperatively to potentiate a complex process like metastasis has not been fully appreciated.
Recent studies have implicated the vitronectin receptor integrin ␣v␤3 in angiogenesis and melanoma cell invasion and metastasis (6-8, 31, 38-40) . In fact, we have recently shown that expression of integrin ␣v␤3 in CS-1 melanoma cells leads to vitronectin-dependent migration and pulmonary metastasis without the apparent need for exogenous cytokine activation (17) . However, integrin ␣v␤3 has a relatively limited tissue distribution, and many tumor cells lacking this integrin readily metastasize, suggesting a requirement of other molecules (39, 40) . In contrast, ␣v␤5, the most widely expressed vitronectin receptor, mediates cell adhesion but is unable to initiate cell motility (16) . However, treatment with agonists of tyrosine kinase receptors or activators of protein kinase C facilitated ␣v␤5-dependent cell spreading and migration on vitronectin (16, 41) . Thus, it appears that integrin ␣v␤5 may be structurally designed to respond to specific cytokine-derived signaling events that enable it to engage the cell's motility machinery. Since the vitronectin receptor ␣v␤5 is widely expressed by many malignant tumor cells (42) , combined with the fact that many cytokines such as IGF-1 are secreted by tumors (43, 44) , we investigated the possible cooperative role of this cytokine and ␣v␤5 in spontaneous tumor cell metastasis in vivo.
In this report and previous studies, evidence is provided that stimulation of ␣v␤5-expressing CS-1, FG, and MCF-7PB cells with either insulin or IGF-1 promoted vitronectin-dependent motility. In fact, we provide evidence that the ␤5CS-1 migratory response was dependent on both expression of ␣v␤5 and cytokine activation since neither ␣v␤5-negative CS-1 cells stimulated with cytokine nor ␤5CS-1 cells in the absence of cytokine migrated toward vitronectin. Interestingly, cytokine stimulation of ␤5CS-1 cells attached to vitronectin caused a specific redistribution and colocalization of ␣-actinin with integrin ␣v␤5. ␣-Actinin has been implicated in cell motility and is known to associate either directly or indirectly with both the actin cytoskeleton and integrin receptors (45) (46) (47) . Therefore, this association between ␣-actinin and ␣v␤5 after cytokine activation may allow ␣v␤5 to engage the cell's motility machinery and promote migration toward vitronectin.
Since tumor cell motility contributes to the invasion and/or dissemination of malignant tumor cells, we investigated the biological relevance of cytokine-activated ␣v␤5-dependent tumor cell motility in two independent in vivo models. We demonstrate that ␤5CS-1, FG, and MCF-7PB tumor cells readily metastasize to the lungs of either chick embryos and/or SCID mice, after stimulation with either insulin or IGF-1. These results have clinical relevance, since primary melanoma tumors that invade vertically into human dermis are often highly metastatic, whereas horizontal growing melanomas in the epidermis are typically benign (48) . The SCID mouse/human chimeric model provided the unique ability to study the invasive and metastatic properties of melanoma cells in the microenviroment of the human skin. In addition, many invasive human carcinoma tumors lack expression of integrin ␣v␤3, but readily express ␣v␤5, IGF-1, and IGF-I receptors that may cooperate to promote metastasis in vivo.
While it has been shown that cytokine stimulation of tumor cells can potentiate tumor growth, little if any changes were observed in tumorgenicity of the cell types tested after stimulation with either insulin or IGF-1, suggesting that cytokine stimulation can selectively influence the invasive and metastatic properties of tumor cells. In fact, it has been reported that ligation of growth factor receptors can activate ras-dependent signaling pathways leading to tumor cell metastasis (49, 50). Our findings are consistent with these results, but suggest the additional involvement of the integrin ␣v␤5 in metastatic behavior. Furthermore, this invasive cellular response depended on both expression of integrin ␣v␤5 and exposure to cytokine, since ␣v␤3-negative FG human pancreatic carcinoma, MCF-7PB breast carcinoma, CS-1 melanoma cells, or ␣v␤5-positive ␤5CS-1 cells in the absence of cytokine exhibited little if any metastatic ability. Moreover, both FG and ␤5CS-1 tumor cell metastasis could be blocked by systemic administration of monoclonal antibody directed to integrin ␣v␤5, thus demonstrating the importance of ␣v␤5 in this process.
These findings have significant consequences for many solid tumors since ␣v␤5 is among the most widely expressed members of the integrin family and has been detected on most normal and transformed adherent cell lines examined (42) . In contrast, the vitronectin receptor ␣v␤3, which promotes cell motility without cytokine stimulation (17) , has a relatively limited cellular distribution compared with that of ␣v␤5 (42, 48, 51) . These results, combined with the fact that cytokines such as IGF-1 can be secreted by many tumors (20-23), suggest a novel mechanism of tumor progression in which ␣v␤5-dependent metastasis occurs.
Finally, results presented here support the notion that adhesion and growth factor receptors influence tumor cell behavior in vivo. Evidence is provided that the spontaneous metastasis of a variety of distinct tumor types can be specifically regulated by the functional cooperation of integrin ␣v␤5 and cytokine-dependent signals. These studies suggest that antagonists of integrin ␣v␤5 and/or IGF-1 may provide novel strategies for the treatment of metastatic disease.
